Fact CheckerSign in

NCT05820334Completed

Multiple Sclerosis and Fatigue Assessment

Fatigue in Multiple Sclerosis Patients; Subjective, Objective and Cognitive Analysis

Source: ClinicalTrials.gov · Last updated 27 Jan 2026

Brief summary (registry, in English)

Fatigue in patients with Multiple Sclerosis (MS) is a problem that is seen without physical exertion and affects the majority of patients. In studies on fatigue in the literature, it has been seen that subjective methods are frequently used by using evaluation scales based on patient statements, but objective evaluation methods are not yet sufficient. This study was planned to compare the measurement results by evaluating fatigue subjectively, objectively and cognitively in MS patients.

Status (registry)
Completed
Study type
Observational
Enrollment
60 (actual)
First submitted
6 Apr 2023
Start date
1 Apr 2023
Primary completion date
1 Dec 2024
Lead sponsor
Asli Demirtaş
NCT number
NCT05820334

What you commit to

  • Study type: Observational
  • Participants enrolled: 60
  • From 1 Apr 2023 to the primary completion date, 1 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Having an orthopedic problem or having a surgery that may affect the lower extremity,

Other illness

  • Having an active infection,
  • Having an additional neurological or circulatory disease that may cause balance disorder, a problem affecting the vision or vestibular tract, or a diagnosis of orthopedic surgery, rheumatological disease,

Other

  • Being diagnosed with MS for less than 1 year,
  • Having had an MS attack in the last 3 months,
  • Being illiterate or unable to communicate in Turkish,
  • Being pregnant,
  • To be included in the physiotherapy and rehabilitation program in the last 3 months.

Who the study is looking for

  • Being between the ages of 18-65,
  • Having a definite diagnosis of Relapsing Remitting MS by a neurologist,
  • Expanded Disability Status Scale (EDSS) score between 1-5.5,
  • To be stable in medical treatment,
  • Being able to stand independently for at least 60 seconds without any assistive device,
  • It is to be above 24 points according to the Mini-Mental State Examination (MMSE) evaluation.

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Gazi University
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.